Primary immunodeficiencies: HSCT experiences of a single center in Turkey.

Erol Cipe F., Adakli Aksoy B., Aydogdu S., Dikme G., Kiykim A., Aydogmus C., ...More

Pediatric transplantation, vol.25, no.7, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 7
  • Publication Date: 2021
  • Doi Number: 10.1111/petr.14063
  • Journal Name: Pediatric transplantation
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Keywords: allogeneic stem cell transplantation, bone marrow transplantation, hematopoietic stem cell transplantation, pediatric transplantation, primary immunodeficiency
  • Istanbul University Affiliated: Yes


Background Primary immunodeficiency diseases (PID) are characterized by the occurrence of frequent infections and are caused by many genetic defects. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment option for the majority of PID. As a Pediatric Hematology-Oncology-Immunology Transplantation Unit, we wanted to present our HSCT experience regarding treatment of primary immunodeficiency diseases.